Sign in
Not yet taking people in NetherlandsPhase 1

Testing an oncolytic virus injected into tumors in pancreatic cancer

Tests ORCA-010, a virus injected into tumors, in adults with metastatic pancreatic cancer.

Key facts

Who runs it
Amsterdam UMC Stichting
Where
Amsterdam, NetherlandsSee the site
Registry title
PANVIRAL: Safety, Feasibility and Immunogenicity of Intra-Tumoral ORCA-010 Oncolytic Virus Administration in Metastatic Pancreatic Cancer – A Single-Center Phase 1 Trial
Status
Not yet recruiting
Phase
Phase 1
People taking part
15 people, planned
Starts
1 Jan 2027
Expected to end
1 Jan 2029
Type of study
Interventional
Record updated
9 October 2026

Who can take part

AI summary

From the trial's eligibility criteria. Machine-read from the registry text on this page, so it can be wrong. The registry text below and the trial team decide who can take part.

The trial is looking for adults with metastatic pancreatic cancer to test the safety and immune response of ORCA-010, an oncolytic virus injected into the tumor.

Age
18 years or older
Sex
All sexes can join
Disease stage
Metastatic pancreatic cancer

Where in Netherlands

  • Amsterdam UMC StichtingAmsterdam, NetherlandsNot yet recruiting

Questions to ask the study team

  1. How often do I need to come in, and for how long each time?
  2. Are travel costs paid?
  3. Can I keep my own doctor?
  4. What happens if I want to stop?

Contact the study team: see the registry record

Print a page for my doctor

Data and sources

Registry record
Listed on the EU's official list of trials (CTIS).
Plain-language title
Testing an oncolytic virus injected into tumors in pancreatic cancerGenerated from the registry record. The registry title is the official one.
AI summary
From the trial's eligibility criteria. Read by machine on 9 November 2026.
Record updated
9 October 2026